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We investigated the ability of the rabbit hemorrhagic disease virus (RHDV) capsid protein (VP60) to interact specifically with the 
minor structural protein VP10, using an in vivo cell-based CheckMate™ Mammalian Two-Hybrid System. RHDV VP60 protein 
interacted specifically with VP10. Immunofluorescence analysis and co-immunoprecipitation with specific antibodies revealed the 
existence of biologically important VP60/VP10 complexes. However, when VP60 was divided into two fragments, the interaction 
between VP60 and VP10 was impaired dramatically. These results will be helpful for further investigating the mechanism of 
RHDV particle assembly. 
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Rabbit hemorrhagic disease virus (RHDV) is an emerging 
disease in rabbits and is considered the single most eco-
nomically important disease of rabbits worldwide. The eti-
ological agent has been identified as a Calicivirus [1], a 
positive-sense, single-stranded RNA virus that is antigeni-
cally related to European brown hare syndrome virus [2,3]. 
The complete genome of the virus has been elucidated for 
the German isolate [4] and shown to comprise a single- 
stranded, positive-sense RNA genome of 7437 nucleotides. 
The genome contains two open reading frames (ORFs), the 
first of which is 2344 codons long (ORF1) and encodes a 
large polyprotein that contains the viral non-structural pro-
teins, as well as the viral coat protein, at the C terminus. 
The genome also has a virus-encoded protein, VPg, attached 
covalently to the 5 end [5], and is polyadenylated at the 3 
end [6]. In RHDV-infected cells, a 2.2-kb subgenomic 
mRNA is transcribed that is colinear with the 3 third of the 
genomic RNA [7]. This mRNA is thought to represent the 
major source of the RHDV capsid protein (VP60); however, 
VP60 is also generated via cleavage of the ORF1-encoded 
polyprotein [8]. A second ORF (ORF2) is located at the 
extreme 3 end of the genome and subgenomic RNAs. The 
start codon for ORF2 is located at nucleotide 7025, shares a 
17-nucleotide overlap with ORF1, but is frame shifted –1 
relative to the capsid ORF. RHDV ORF2 is 117 amino acids 
long and encodes a polypeptide of 12.7 kD (VP10), which is 
considered to be a component of RHDV virions [9–11]. VP10 
is conserved throughout all caliciviruses, suggesting that it 
may play a role in virus replication or assembly. 
To date, the precise mechanism of RHDV virion assem-
bly is not clear. However, recent research has shown that 
the ORF3 23 kD of Norwalk virus, another important 
member of the Caliciviridae, is able to interact with VP10 
capsid protein and be incorporated into virus-like particles 
(VIPs)[12]. We assume that the similar interaction also ex-
ists in RHDV, and studies on the interactions between VP60 
and VP10 will be helpful for exploring the above questions. 
In this study, we revealed the specific interaction between 
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VP60 and VP10 in mammalian cells by the use of different 
approaches. 
1  Materials and methods 
1.1  Plasmids construction 
The full-length coding regions of RHDV VP60 and VP10 
were amplified by RT-PCR using the Moloney murine leu-
kemia virus reverse transcriptase, and Pfu DNA polymerase 
using RHDV genomic RNA isolated from CHA/JX/97 
strain of RHDV as a template. The primers, used to amplify 
VP60, VP10 VP60C, VP60N were listed as following: 
VP60F: 5-CTGTCTAGAXba IATGGAGGGCAAAACCCGC- 
3; VP60R: 5-AGTGGTACCKpn ITCAGACATAAGAAA- 
AGCC-3; VP10F: 5-CTGTCTAGAXba I ATGGCTTTTCT- 
TATGTCTG-3; VP10R: 5-AGTGGTACCKpn I TCAAAC- 
ACTGGACTCGCC-3. After standard PCR process, PCR 
products were digested by these enzymes (Kpn I and Xba I) 
and cloned into eukaryotic expression plasmids pCI, pBIND 
or pACT (Promega, USA), respectively. The resulting 
clones were designated as pCI-VP60, pCI-VP10, pBIND- 
VP60 and pACT-VP10. To demonstrate that the interaction 
between VP60 and VP10 depended on the intact structure of 
VP60, VP60 was divided into two fragments: N-290aa and 
C-300aa. The corresponding coding regions were amplified 
by RT-PCR essentially as described above. The primers 
were as following: VP60CF: 5-CTGTCTAGAXba I ATGC- 
GGTTTGCCGACATT-3; VP60CR: 5-ACTGGTACCKpn I 
TCAGACATAAGAAAAGCC-3; VP60NF: 5-CTGTCT- 
AGAXba I ATGGAGGGCAAAACCGGC-3; VP60NR: 5- 
AGTGGTACCKpn I TAGAGGGCTTGACCAGCC-3. PCR 
fragments were cloned into pBIND. The resulting clones 
were designated as pBIND-VP60N and pBIND-VP60C. All 
clones were verified by sequencing, and their sequence in-
formation as well as that for all primers is available from 
the authors upon request. 
1.2  Antibodies 
Mouse polyclonal serum against RHDV VP10 was used for 
detection of VP10 protein. Rabbit polyclonal serum against 
full-length RHDV VP60 was used to detect VP60. 
1.3  Cells 
HeLa cells were obtained from the China Center for Type 
Culture Collection and were grown in Dulbecco’s Modified 
Eagle’s Medium supplemented with 10% fetal calf serum 
and antibiotics (100 U/mL penicillin and 100 μg/mL strep-
tomycin) at 37°C and 5% CO2. 
1.4  Transfection of HeLa cells 
HeLa cells were grown to 80% confluence and transfected 
with different combinant plasmids (Table 1) for 4 h at 37°C 
with a mixture containing 2–5 μg plasmid DNA and 10 μL 
Lipofectamine 2000 (Invitrogen, USA), according to the 
supplier’s instructions.  
1.5  Luciferase activity assay 
HeLa cells at 24 h post-transfection were lysed and lucifer-
ase activity was assayed using the Dual-Luciferase Reporter 
Assay System (Promega). 
1.6  Co-immunoprecipitation 
pCI-VP60 and pCI-VP10 were co-transfected into HeLa 
cells. After 48 h incubation, the transfected HeLa cells were 
lysed in IGEPAL lysis buffer (10 mmol/L Tris (pH 7.5), 10 
mmol/L NaCl, 1 mmol/L EDTA, 0.5% IGEPAL CA-630, 1 
mmol/L PMSF, and EDTA-free protease inhibitor cocktail 
(Roche, USA)) for 30 min on ice. Nuclei and nonlysed cells 
were removed by centrifugation at 1000  g for 10 min. 
Protein concentration in cleared cell lysates was analyzed 
using the Bradford assay and the amount of lysate corre-
sponding to 500 μg total protein was incubated with 
VP10-specific antibody bound to agarose beads for 2 h at 
4°C.  
The suspension was placed on the protein purification 
column, agarose beads were washed twice with lysis buffer 
containing 150 mmol/L NaCl, and proteins bound to sorbent 
were denatured by boiling in 50 μL Laemmli buffer for 5 
min. Ten-microliter aliquots of obtained sample were sepa-
rated by 12% SDS-PAGE and transferred onto nitrocellu-
lose membranes. To characterize the interaction between 
RHDV VP60 and VP10 in HeLa cells, the infected cells 
were collected at 24 h post-infection by scraping into PBS, 
followed by centrifugation (10 min, 2000 r/min). Collected 
cells were treated with 1 mL cold lysis buffer (50 mmol/L 
Tris (pH 7.5), 50 mmol/L NaCl, 10% glycerol, 1 mmol/L 
DTT, 1 mmol/L PMSF, and EDTA-free protease inhibitor 
cocktail) for 30 min on ice. Then, cells were sonicated with 
an ultrasonic homogenizer (20 times for 5 s at 20-s intervals) 
and the membranous fraction of the cells was collected by 
centrifugation at 15000  g for 20 min at 4°C. The mem-
brane pellet was treated with 1 mL RIPA buffer (50 mmol/L 
Tris (pH 7.5), 150 mmol/L NaCl, 1 mmol/L EDTA, 1% 
IGEPAL CA-630, 1% sodium deoxycholate, 0.1% SDS, 1 
mmol/L PMSF, and EDTA-free protease inhibitor cocktail)  
Table 1  Groups of plasmid transfection 
Groups pACT pBIND pG5luc 
Group I: positive pACT-myOD pBIND-ID pG5luc 
Group II: negative pACT pBIND pG5luc 
Group III: VP10+VP60 pACT-VP60 pBIND-VP10 pG5luc 
Group IV: VP10+VP60C pACT-VP60C pBIND-VP10 pG5luc 
Group V: VP10+VP60N pACT-VP60N pBIND-VP10 pG5luc 
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for 15 min on ice, and sonicated again as described above. 
The nonsoluble fraction was removed by centrifugation at 
15000  g for 20 min. Total protein concentration in the 
supernatant was analyzed using the Bradford assay and the 
amount of lysate corresponding to 500 μg total protein was 
used for co-immunoprecipitation. The VP60 protein was 
precipitated with specific mouse monoclonal antibody; in 
reciprocal experiments, VP10 protein was precipitated with 
the respective rabbit polyclonal serum by use of Protein A 
Sepharose™ CL-4B (Amersham Biosciences, USA) in RIPA 
buffer. The immunoprecipitated proteins were denatured by 
boiling in 50 μL Laemmli buffer for 5 min, and 10-μL sam-
ples were used for Western blot analysis with appropriate 
antibodies, to detect co-immuno-precipitated proteins. 
1.7  Cellular localization of RHDV VP60, VP10, VP60N 
and VP60C protein by immune confocal  
The plasmids pCI-VP60, pCI-VP10, pCI-VP60N and pCI- 
VP60C were transfected into HeLa cells respectively, as 
described in Section 1.4. The localization of VP60, VP10, 
VP60N and VP60C was examined using rabbit anti-VP60 
and VP10 serum at dilutions from 1:50 to 1:400, together 
with secondary goat anti-rabbit FITC antibody (Sigma, 
USA). Both the primary and secondary antibody was used 
in the optimal dilutions for indirect immunofluorescence 
assay (IFA). 
1.8  Confirmation of VP60 and VP10 protein-protein 
interactions via co-localization using two-color co-im- 
munofluorescence 
pCI-VP60, pCI-VP10, pCI-VP60N and pCI-VP60C plas-
mids were co-transfected into HeLa cells seeded on glass 
coverslips, in the following two-plasmid combinations: 
VP60+VP10, VP60N+VP10, and VP60C+VP10. After 48 h, 
cells were harvested. The relationship of VP60N+VP10, 
VP60+VP10 and VP60C+VP10 to each other was examined 
using the mouse anti-VP10 and rabbit anti-VP60 sera at 
dilutions from 1:50 to 1:400, together with secondary goat 
anti-rabbit Cy3 antibody (ProteinTech, USA) and goat anti- 
rabbit FITC antibody (Sigma). 
2  Results  
2.1  Detection of luciferase activity  
Interactions between VP60 and VP10 in transfected cells 
were studied using the CheckMate™ Mammalian Two- 
Hybrid System. HeLa cells were grown to 80% confluence 
and transfected with various combinations of plasmids (Ta-
ble 1). HeLa cells at 24 h post-transfection were lysed and 
the activity of luciferase was assayed using the Dual-   
Luciferase Reporter Assay System. The results showed that 
the luciferase of Group III (VP10+VP60) was stronger than 
that of Group II (negative control), suggesting that there 
was stronger interaction between VP60 and VP10. The re-
sults also revealed that the enzymatic activity of Group IV 
(VP10+VP60C) and Group V (VP10+VP60N) was signifi-
cantly lower than that of Group III (Figure 1), indicating 
that the interaction was impaired.  
2.2  Subcellular localization of proteins 
A high level of transient expression of VP10, VP60, VP60N 
and VP60C proteins was achieved in transfected HeLa cells. 
All of the proteins were co-localized predominantly in the 
perinuclear area (Figure 2(a)–(d)). As a part of VP60, 
VP60C and VP60N proteins have a low level of transient 
expression, but they still could be recognized by specific 
antibodies. 
2.3  Confirmation of the interactions between VP60 
and VP10 via co-localization using two-color co-immu- 
nofluorescence 
Co-localization of RHDV VP60 and VP10 was first ana-
lyzed by use of co-transfection of HeLa cells with plasmids 
pCI-VP60, pCI-VPN, pCI-VPC and pCI-VP10. We found 
that three combinations of co-expressed proteins co-local- 
ized in a predominantly perinuclear area (Figure 3(a)–(c)). 
For VP60 and VP10 co-expression, both proteins were al-
most exclusively co-localized over the cell cytoplasm (Fig-
ure 3(a)). Although co-expression of VP10 and VP60C or 
VP60N was detected, the amount of complex was very low 
in cell cytoplasm (Figure 3(b) and (c)). Taken together, the-
se results indicate that co-localization of VP60 with VP10 
may depend on the integrity of VP60. 
2.4  Interactions of VP10-VP60 proteins 
Transient expression of VP10 and VP60 proteins was 
achieved in transfected HeLa cells and detected by Western 
blotting (data not shown). Interactions between VP10 and 
VP60 proteins in transfected cells were studied by co-   
immunoprecipitation. Protein complexes formed in cells  
 
 
Figure 1  Luciferase detection of Group III (VP10+VP60), Group IV 
(VP10+VP60C) and Group V (VP10+VP60N) by CheckMate™ Mamma-
lian Two-Hybrid System. For the chart, the firefly luciferase of Group I 
(positive), Group II (negative), Group III (VP10+VP60), Group IV 
(VP10+VP60C) and Group V (VP10+VP60N) was detected, which was 
normalized by Renilla luciferase. 
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Figure 2  Subcellular localization of VP10, VP60, VP60N and VP60C proteins. HeLa cells were analyzed 48 h post-transfection. The names of the ex-
pressed proteins are shown on each panel. Recombinant VP10 (a), VP60 (b), VP60N (c) and VP60C (d) proteins in HeLa cells were detected with rabbit 
anti-VP60 and VP10 sera at dilutions from 1:50 to 1:400, together with the secondary goat anti-rabbit FITC antibody. Images obtained by confocal Bio-Rad 
MRC-1024 microscope. 
 
Figure 3  Subcellular localization of VP10 and VP60, VP10 and VP60N, and VP10 and VP60C in HeLa cells 48 h post-transfection. (a) HeLa cells dou-
ble-transfected with pCI-VP10 and pCI-VP60. Cells were fixed with 4% paraformaldehyde and VP10 was detected by mouse anti-VP10 polyclonal antibody 
and anti-mouse FITC-conjugated antibody, VP60 was detected by rabbit anti-VP60 polyclonal antibody and goat anti-rabbit Cy3 antibody. (b) HeLa cells 
double-transfected with pCI-VP10 and pCI-VP60N. Cells were fixed with 4% paraformaldehyde and VP10 was detected by mouse anti-VP10 polyclonal 
antibody and anti-mouse FITC-conjugated antibody. VP60N was detected by rabbit anti-VP60 polyclonal antibody and goat anti-rabbit Cy3 antibody. (c) 
HeLa cells double-transfected with pCI-VP10 and pCI-VP60C. Cells were fixed with 4% paraformaldehyde and VP10 was detected by mouse anti-VP10 
polyclonal antibody and anti-mouse FITC-conjugated antibody. VP60C was detected by rabbit anti-VP60 polyclonal antibody and goat anti-rabbit Cy3 anti-
body. Names of proteins are indicated in each panel.  
transfected with pCI-VP10 and pCI-VP60 were precipitated 
under native conditions bound to agarose beads, and co- 
precipitated proteins were detected with rabbit polyclonal
antibodies against VP10 (Figure 4). 
3  Discussion 
There are only two structural proteins (VP60 and VP10) in 
mature RHDV virions. VP60 is the major capsid protein and 
can self assembly without the need for any other protein. 
However, it has been shown that the expression level of 
VP60 is related to that of VP10 [13,14]. VP10 is the minor 
structural protein of RHDV, and its exact biological func-
tion is not clear. Some research has suggested that VP10 
can increase the stability of the genome and promote capsid 
assembly, and its expression is regulated by the coding re-
gion of VP60. In theory, as a structural protein, VP10  
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Figure 4  Immunoprecipitation of VP60/VP10 complex from HeLa cells 
co-transfected with pCI-VP60 and pCI-VP10. Immunoprecipitation was 
performed by use of agarose beads conjugated with VP10 antibody; pre-
cipitated samples were subjected to SDS-PAGE and Western blotting. 
Twenty micrograms of total cellular protein was loaded in lanes a–c. Lane 
a: lysate from HeLa cells co-transfected with pCI-VP10. Lane b: lysate 
from HeLa cells co-transfected with pCI-VP60. Lane c: immune complex-
es of VP10 and VP60 proteins from HeLa cells co-transfected with pCI- 
VP60 and pCI-VP10. All the samples were detected by Western blotting 
using VP10 antibody. 
should participate in viral capsid formation. Several inves-
tigations on Norwalk virus and Feline calicivirus have 
shown that VP3 (similar to RHDV VP10) can interact with 
capsid protein and be incorporated into VIPs [15]. However, 
no experimental data have demonstrated that VP10 may be 
involved in RHDV particle assembly or that it is a capsid 
component. We hypothesize that there is a certain interac-
tion between VP60 and VP10, which may promote RHDV 
capsid assembly.  
In the present study, we believe that we proved for the 
first time that RHDV VP60 and VP10 could form a biolog-
ically important complex in vivo, and that the complex de-
pends on the intact structure of VP60. If VP60 was divided 
into two fragments, the interaction could be impaired dra-
matically. The findings suggest that the interactions be-
tween VP10 and VP60 may occur in the process of virion 
assembly, and VP10 may be involved in this process, which 
may help with virus maturation. This speculation needs fur-
ther research for confirmation. In a word, the results of this 
paper may be helpful for further studies of RHDV virus 
particle assembly, maturation and release.  
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